Medicx Fund Regulatory News (MXF)

For immediate release

17 July 2013

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Correction - further issue of shares

Further to the announcement made by the Board of MedicX Fund Limited on 15 July 2013 in which it noted that the Company had issued 3,700,000 new ordinary shares, subject to Admission, the Board confirms that such shares were issued to satisfy general market demand.

- End -

For further information please contact:

MedicX Group +44 (0) 1483 869 500

Keith Maddin, Chairman

Mike Adams, Chief Executive Officer

Mark Osmond, Chief Financial Officer

MedicX Fund Limited +44 (0) 1481 723 450

David Staples, Chairman

Canaccord Genuity Limited +44 (0) 20 7523 8000

Andrew Zychowski / Lucy Lewis

Buchanan +44 (0) 20 7466 5000

Charles Ryland / Sophie McNulty

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange in November 2006. It has committed investment of £449.7 million and a portfolio of 122 properties.

The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 29 people operating across the UK. 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.